These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
235 related articles for article (PubMed ID: 37696937)
41. Revisiting COVID-19 vaccine hesitancy around the world using data from 23 countries in 2021. Lazarus JV; Wyka K; White TM; Picchio CA; Rabin K; Ratzan SC; Parsons Leigh J; Hu J; El-Mohandes A Nat Commun; 2022 Jul; 13(1):3801. PubMed ID: 35778396 [TBL] [Abstract][Full Text] [Related]
42. Factors influencing hesitancy towards adult and child COVID-19 vaccines in rural and urban West Africa: a cross-sectional study. Faye SLB; Krumkamp R; Doumbia S; Tounkara M; Strauss R; Ouedraogo HG; Sagna T; Barry AM; Mbawah AK; Doumbia CO; Diouf S; Cisse K; Harding M; Donven P; May J; Puradiredja DI; Fusco D; BMJ Open; 2022 Apr; 12(4):e059138. PubMed ID: 35418436 [TBL] [Abstract][Full Text] [Related]
43. COVID-19 vaccine hesitancy in adults with multiple sclerosis in the United States: A follow up survey during the initial vaccine rollout in 2021. Ehde DM; Roberts MK; Humbert AT; Herring TE; Alschuler KN Mult Scler Relat Disord; 2021 Sep; 54():103163. PubMed ID: 34325399 [TBL] [Abstract][Full Text] [Related]
45. Determinants of COVID-19 Vaccine Hesitancy: A Cross-Sectional Study on a Mexican Population Using an Online Questionnaire (COV-AHQ). Delgado-Gallegos JL; Padilla-Rivas GR; Zúñiga-Violante E; Avilés-Rodríguez G; Arellanos-Soto D; Gastelum-Arias LJ; Franco Villareal H; Cosío-León MLÁ; Romo-Cardenas GS; Moreno-Treviño MG; Moreno-Cuevas JE; Islas JF Front Public Health; 2021; 9():728690. PubMed ID: 34900890 [TBL] [Abstract][Full Text] [Related]
46. Determinants of COVID-19 vaccine readiness and hesitancy among adults in sub-Saharan Africa. Abubakari SW; Workneh F; Asante KP; Hemler EC; Madzorera I; Wang D; Ismail A; Assefa N; Azemraw T; Lankoande B; Nuhu AR; Chukwu A; Mapendo F; Millogo O; Olufemi AA; Okpara D; Boudo V; Mwanyika-Sando M; Berhane Y; Baernighausen T; Oduola A; Vuai S; Sie A; Soura A; Killewo J; Tajudeen R; Fawzi WW; Smith ER PLOS Glob Public Health; 2023; 3(7):e0000713. PubMed ID: 37450441 [TBL] [Abstract][Full Text] [Related]
47. Peoples' attitude toward COVID-19 vaccine, acceptance, and social trust among African and Middle East countries. Asadi Faezi N; Gholizadeh P; Sanogo M; Oumarou A; Mohamed MN; Cissoko Y; Saliou Sow M; Keita BS; Baye YAM; Pagliano P; Akouda P; Soufiane S; Iknane AA; Safiatou Diallo MO; Gansane Z; Ali Khan B; Köse Ş; Allahverdipour H; Ganvarov K; Soumaré M; Asgharzadeh M; Dao S; Samadi Kafil H Health Promot Perspect; 2021; 11(2):171-178. PubMed ID: 34195040 [No Abstract] [Full Text] [Related]
48. Factors Associated With Marshallese and Hispanic Adults' Willingness to Receive a COVID-19 Booster Dose. Purvis RS; Vincenzo JL; Spear M; Moore R; Patton SK; Callaghan-Koru J; McElfish PA; Curran GM J Prim Care Community Health; 2023; 14():21501319231171440. PubMed ID: 37191303 [TBL] [Abstract][Full Text] [Related]
49. Assessing Parents' Knowledge, Attitudes, and Practices Toward Vaccinating Children (Five to 15 Years Old) Against COVID-19 in the United Arab Emirates. Bourguiba A; AbuHijleh S; Nached Y; Waleed D; Farghaly S; AlOlama F Cureus; 2022 Dec; 14(12):e32625. PubMed ID: 36654580 [TBL] [Abstract][Full Text] [Related]
50. Predictors of COVID-19 vaccine uptake among adults in South Africa: multimethod evidence from a population-based longitudinal study. Maughan-Brown B; Eyal KC; Njozela L; Buttenheim AM BMJ Glob Health; 2023 Aug; 8(8):. PubMed ID: 37541692 [TBL] [Abstract][Full Text] [Related]
51. Barriers and facilitators of childhood COVID-19 vaccination among parents: A systematic review. Khan YH; Rasheed M; Mallhi TH; Salman M; Alzarea AI; Alanazi AS; Alotaibi NH; Khan SU; Alatawi AD; Butt MH; Alzarea SI; Alharbi KS; Alharthi SS; Algarni MA; Alahmari AK; Almalki ZS; Iqbal MS Front Pediatr; 2022; 10():950406. PubMed ID: 36507133 [TBL] [Abstract][Full Text] [Related]
52. The Impact of Priority Settings at the Start of COVID-19 Mass Vaccination on Subsequent Vaccine Uptake in Japan: One-Year Prospective Cohort Study. Hori D; Takahashi T; Ozaki A; Tabuchi T JMIR Public Health Surveill; 2023 Jul; 9():e42143. PubMed ID: 37235691 [TBL] [Abstract][Full Text] [Related]
53. Determinants of COVID-19 vaccine hesitancy and uptake in sub-Saharan Africa: a scoping review. Deml MJ; Githaiga JN BMJ Open; 2022 Nov; 12(11):e066615. PubMed ID: 36400736 [TBL] [Abstract][Full Text] [Related]
54. COVID-19 vaccine hesitancy in Zambia: a glimpse at the possible challenges ahead for COVID-19 vaccination rollout in sub-Saharan Africa. Carcelen AC; Prosperi C; Mutembo S; Chongwe G; Mwansa FD; Ndubani P; Simulundu E; Chilumba I; Musukwa G; Thuma P; Kapungu K; Hamahuwa M; Mutale I; Winter A; Moss WJ; Truelove SA Hum Vaccin Immunother; 2022 Dec; 18(1):1-6. PubMed ID: 34227914 [TBL] [Abstract][Full Text] [Related]
55. COVID-19 vaccine acceptance and associated factors in 13 African countries: A systematic review and meta-analysis. Azanaw J; Endalew M; Zenbaba D; Abera E; Chattu VK Front Public Health; 2022; 10():1001423. PubMed ID: 36761336 [TBL] [Abstract][Full Text] [Related]
56. Vaccine hesitancy comes in waves: Longitudinal evidence on willingness to vaccinate against COVID-19 from seven European countries. Sabat I; Neumann-Böhme S; Barros PP; Torbica A; van Exel J; Brouwer W; Stargardt T; Schreyögg J Vaccine; 2023 Aug; 41(36):5304-5312. PubMed ID: 37460356 [TBL] [Abstract][Full Text] [Related]
57. Barriers to COVID-19 vaccination among older adults in Mexico City. Gaitán-Rossi P; Mendez-Rosenzweig M; García-Alberto E; Vilar-Compte M Int J Equity Health; 2022 Jun; 21(1):85. PubMed ID: 35717236 [TBL] [Abstract][Full Text] [Related]
58. COVID-19 vaccination hesitancy among southern rural veterans with cancer in the arkansas-louisiana-texas (ArkLATX) region. Haddad P; McGovern P; McGowen M; Gallagher K; Hammoud D; Houston L; Craig M; Phelan M Ann Fam Med; 2022 Apr; 20(20 Suppl 1):. PubMed ID: 36857124 [TBL] [Abstract][Full Text] [Related]